APA

Gori S., Rimondini S., De Angelis V., Colozza M., Bisagni G., Moretti G., Sidoni A., Basurto C., Aristei C., Anastasi P. & Crinò L. (20080325). Central nervous system metastases in HER-2 positive metastatic breast cancer patients treated with trastuzumab: incidence, survival, and risk factors. : The oncologist.

Chicago

Gori Stefania, Rimondini Simonetta, De Angelis Verena, Colozza Mariantonietta, Bisagni Giancarlo, Moretti Gabriella, Sidoni Angelo, Basurto Carlo, Aristei Cynthia, Anastasi Paola and Crinò Lucio. 20080325. Central nervous system metastases in HER-2 positive metastatic breast cancer patients treated with trastuzumab: incidence, survival, and risk factors. : The oncologist.

Harvard

Gori S., Rimondini S., De Angelis V., Colozza M., Bisagni G., Moretti G., Sidoni A., Basurto C., Aristei C., Anastasi P. and Crinò L. (20080325). Central nervous system metastases in HER-2 positive metastatic breast cancer patients treated with trastuzumab: incidence, survival, and risk factors. : The oncologist.

MLA

Gori Stefania, Rimondini Simonetta, De Angelis Verena, Colozza Mariantonietta, Bisagni Giancarlo, Moretti Gabriella, Sidoni Angelo, Basurto Carlo, Aristei Cynthia, Anastasi Paola and Crinò Lucio. Central nervous system metastases in HER-2 positive metastatic breast cancer patients treated with trastuzumab: incidence, survival, and risk factors. : The oncologist. 20080325.